Browsing by Author WONG, VKC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 6 of 6
TitleAuthor(s)Issue DateViews
 
3-weekly Daratumumab-imid-dexamethasone Is Highly Efficacious And Cost-effective In Relapsed/refractory Multiple Myeloma
Proceeding/Conference:The 17th International Myeloma Workshop, 2019
Chim, JCSWong, VKCAu, YLEKwong, YL
2019
82
 
3-weekly Daratumumab-IMiD-dexamethasone is highly efficacious, hence financially affordable with enormous economic impacy for relapsed/ refractory Multiple Myeloma in less affluent counties
Proceeding/Conference:The 24th Congress of European Haematology Association (EHA)
Chim, JCSWong, VKCAu, YLEKwong, YL
2019
 
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma
Journal:Hematology
Chim, CSKumar, SWong, VKCNgai, CKwong, YL
2021
20
 
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Journal:Emerging Microbes & Infections
Yan, VKCWan, YFEYe, XMok, HYLai, TTFChui, SLCLi, XWong, CKHLi, PHMa, TQin, XSWong, VKCTsang, TCTsui, SHChui, WCMCowling, BJLeung, GMLau, WCSWong, ICKChan, EWY
2022
2
 
Opioid therapy for chronic non-cancer pain: guidelines for Hong Kong
Journal:Hong Kong Medical Journal
Cheung, CWChan, TCWChen, PPChu, MCChui, WCMHO, PTLam, FLaw, SWLee, JLYWong, SHSWong, VKC
2016
 
Review of Newly Registered Oncology Drugs in Hong Kong
Journal:Hong Kong Pharmaceutical Journal
LEE, SKCHEN, XCHENG, TYCHEUNG, WKCHEUNG, WYCHOI, SYCHONG, HYCHU, LSCHUNG, KLKFUNG, KHHO, CYHO, KYKIP, RYYKO, CXKONG, KTKWAN, HSEWIG, CLYWONG, VKCChim, JCS
2016
Showing results 1 to 6 of 6